Home / Anti-infectives / Adefovir Dipivoxil
ATC J05AF08 · Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Adefovir Dipivoxil shortage
As of 2 Nov 2026, Adefovir Dipivoxil has a reported shortage in 1 of the 15 countries we track (Canada), covering 1 product from 1 company.
Countries1/15
Products1packs or presentations
Companies10 listed
Short since30 Jun 20224.3 years ago
Earliest returnnot givencompany estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
Canada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group J05AF · Nucleoside and Nucleotide Reverse Transcriptase InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | AA-ADEFOVIR (30 BTL) | AA PHARMA INC | 30 Jun 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.